カテゴリ： Allied Market Research, サービス/金融, 世界

世界の不妊治療サービス市場2020年-2027年：処置別（ICSI IVF、IUI、非ICSI IVF、代理出産、その他）、サービス別、エンドユーザー別

■ 英語タイトル：Fertility Services Market by Procedure (IVF with ICSI, IUI, IVF without ICSI, Surrogacy, and Others), Service (Fresh Non-donor, Frozen Non-donor, Egg & Embryo Banking, Fresh Donor, and Frozen Donor), and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Global Opportunity Analysis and Industry Forecast, 2020–2027
	■ 発行会社/調査会社：Allied Market Research ■ 商品コード：ALD21JU014 ■ 発行日：2021年4月 ■ 調査対象地域：グローバル ■ 産業分野：サービス ■ ページ数：206 ■ レポート言語：英語 ■ レポート形式：PDF ■ 納品方式：Eメール（受注後24時間以内）

■ 販売価格オプション（消費税別）

Single User	USD6,168 ⇒換算￥900,528	見積依頼/購入/質問フォーム
5 User	USD6,929 ⇒換算￥1,011,634	見積依頼/購入/質問フォーム
Enterprise User	USD9,663 ⇒換算￥1,410,798	見積依頼/購入/質問フォーム

※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[世界の不妊治療サービス市場2020年-2027年：処置別（ICSI IVF、IUI、非ICSI IVF、代理出産、その他）、サービス別、エンドユーザー別]についてメールでお問い合わせはこちら

Allied Market Research社の本調査レポートは、世界の不妊治療サービス市場について調査し、イントロダクション、エグゼクティブサマリー、市場概要、処置別（ICSI IVF、IUI、非ICSI IVF、代理出産、その他）分析、サービス別（新鮮非ドナー、凍結非ドナー、卵・胚バンキング、新鮮ドナー、凍結ドナー）分析、エンドユーザー別（不妊治療クリニック、病院、手術センター、臨床研究機関）分析、地域別分析、企業情報などを整理しました。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界の不妊治療サービス市場規模：処置別（ICSI IVF、IUI、非ICSI IVF、代理出産、その他）
・世界の不妊治療サービス市場規模：サービス別（新鮮非ドナー、凍結非ドナー、卵・胚バンキング、新鮮ドナー、凍結ドナー）
・世界の不妊治療サービス市場規模：エンドユーザー別（不妊治療クリニック、病院、手術センター、臨床研究機関）
・世界の不妊治療サービス市場規模：地域別
・企業情報

*** レポート概要（サマリー）***

The global fertility services market generated $20,388.61 million in 2019 and is projected to reach $25,709.64 million by 2027, growing at a CAGR of 15.9% from 2020 to 2027.

Fertility services are treatments that assist in treating infertility in patients. In vitro fertilization (IVF), surrogacy, artificial insemination, and others are different forms of infertility services, which aid couples with infertility problems, single mothers, and the lesbian, gay, bisexual and trans (LGBT) community to procreate.

The global fertility services market is expected to witness a substantial growth in the future, owing to high incidence of infertility cases, emerging trend of delayed pregnancies among women, rise in technological advancements in fertility procedures, and increased rate of gamete donations. Furthermore, rise in health awareness on fertility issues, availability of fertility treatments, increase in disposable income, and favorable reimbursement policies further augment the market growth.

Recent innovations in IVF technology, such as embryoscope and capsule IVF, are projected to boost the demand for fertility devices in the future. However, strenuous maintenance issues, high cost of devices; multiple pregnancies, i.e., the delivery of twins, triplets, and others, associated with fertility treatments; and ethical considerations are projected to hinder the market growth. Moreover, rise in new fertility clinics and increase in same-sex marriages are projected to offer lucrative growth opportunities in future. In addition, rise in fertility tourism is expected to provide ample growth opportunities especially in the developing economies.

The global fertility services market is classified into procedure, service, end user, and region. By procedure, the market is divided into IVF with intracytoplasmic sperm injection (ICSI), surrogacy, IVF without ICSI (intracytoplasmic sperm injection), intrauterine insemination (IUI), surrogacy, and others. By service, it is categorized into fresh non-donor, frozen non-donor, egg & embryo banking, fresh donor, and frozen donor. By end user, the market is segmented into fertility clinics, hospitals, surgical centers, and clinical research institutes. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS
• The study provides an in-depth analysis of the fertility services market, and the current trends and future estimations to elucidate the imminent investment pockets
• It presents a quantitative analysis of the market from 2019 to 2027 to enable stakeholders to capitalize on the prevailing market opportunities
• Extensive analysis of the market based on procedures, services, and end users assists to understand the trends in the industry
• Key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market

KEY MARKET SEGMENTS
By Procedure
• IVF with ICSI
• IUI
• IVF without ICSI
• Surrogacy
• Others

By Service
• Fresh Non-donor
• Frozen Non-donor
• Egg & Embryo Banking
• Fresh Donor
• Frozen Donor

By End User
• Fertility Clinics
• Hospitals
• Surgical Centers
• Clinical Research Institutes

By Region
North America
• U.S.
• Canada
• Mexico
Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
Asia-Pacific
• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia-Pacific
LAMEA
• Latin America
• Middle East
• Africa

LIST OF KEY PLAYERS PROFILED IN THE REPORT
• Apollo Hospitals Enterprise Ltd
• Care Fertility Group Ltd
• Carolinas Fertility Institute
• City Fertility
• Fertility Associates Limited
• Genea Limited
• Medicover Group
• Monash IVF Group Limited
• Progyny Inc.
• Virtus Health
List of other players in the value chain (profiles not included in the report):
• INVO Bioscience
• IVFtech ApS

*** レポート目次（コンテンツ）***

CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five force analysis
3.4.Government regulations

3.4.1.U.S.
3.4.2.Europe

3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Continuous decline in fertility rates
3.5.1.2.Delayed pregnancies in women
3.5.1.3.Technological advancements with respect to fertility treatment

3.5.2.Restraints

3.5.2.1.High treatment costs of ARTs in developed countries
3.5.2.2.Inadequate reimbursement policies

3.5.3.Opportunity
3.5.3.1.Rise in fertility tourism

3.6.COVID-19 impact on the fertility services market
3.7.Number of fertility service centers

CHAPTER 4:FERTILITY SERVICES MARKET, BY PROCEDURE

4.1.Overview

4.1.1.Market size and forecast

4.2.IVF with ICSI

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast

4.3.IUI

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast

4.4.IVF without ICSI

4.4.1.Key market trends growth factors, and opportunities
4.4.2.Market size and forecast

4.5.Surrogacy

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast

4.6.Others

4.6.1.Key market trends, growth factors, and opportunities
4.6.2.Market size and forecast

CHAPTER 5:FERTILITY SERVICES MARKET, BY SERVICE

5.1.Overview

5.1.1.Market size and forecast

5.2.Fresh non-donor

5.2.1.Market size and forecast

5.3.Frozen non-donor

5.3.1.Market size and forecast

5.4.Egg & embryo banking

5.4.1.Market size and forecast

5.5.Fresh donor

5.5.1.Market size and forecast

5.6.Frozen donor

5.6.1.Market size and forecast

CHAPTER 6:FERTILITY SERVICES MARKET, BY END USER

6.1.Overview

6.1.1.Market size and forecast

6.2.Fertility clinics

6.2.1.Market size and forecast

6.3.Hospitals

6.3.1.Market size and forecast

6.4.Surgical centers

6.4.1.Market size and forecast

6.5.Clinical research institutes

6.5.1.Market size and forecast

CHAPTER 7:FERTILITY SERVICES MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country
7.2.3.Market size and forecast, by procedure
7.2.4.Market size and forecast, by service
7.2.5.Market size and forecast, by end user

7.2.5.1.U.S. market size and forecast, by procedure
7.2.5.2.U.S. Market size and forecast, by service
7.2.5.3.U.S. Market size and forecast, by end user
7.2.5.4.Canada size and forecast, by procedure
7.2.5.5.Canada Market size and forecast, by service
7.2.5.6.Canada Market size and forecast, by end user
7.2.5.7.Mexico market size and forecast, by procedure
7.2.5.8.Mexico Market size and forecast, by service
7.2.5.9.Mexico Market size and forecast, by end user

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe Market size and forecast, by country
7.3.3.Europe Market size and forecast, by procedure
7.3.4.Europe market size and forecast, by service
7.3.5.Europe market size and forecast, by end user

7.3.5.1.Germany market size and forecast, by procedure
7.3.5.2.Germany market size and forecast, by service
7.3.5.3.Germany market size and forecast, by end user
7.3.5.4.France market size and forecast, by procedure
7.3.5.5.France market size and forecast, by service
7.3.5.6.France market size and forecast, by end user
7.3.5.7.UK market size and forecast, by procedure
7.3.5.8.UK market size and forecast, by service
7.3.5.9.UK market size and forecast, by end user
7.3.5.10.Italy market size and forecast, by procedure
7.3.5.11.Italy Market size and forecast, by service
7.3.5.12.Italy market size and forecast, by end user
7.3.5.13.Spain market size and forecast, by procedure
7.3.5.14.Spain Market size and forecast, by service
7.3.5.15.Spain Market size and forecast, by end user
7.3.5.16.Russia market size and forecast, by procedure
7.3.5.17.Russia Market size and forecast, by service
7.3.5.18.Russia market size and forecast, by end user
7.3.5.19.Rest of Europe market size and forecast, by procedure
7.3.5.20.Rest of Europe market size and forecast, by service
7.3.5.21.Rest of Europe market size and forecast, by end user

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country
7.4.3.Asia-Pacific market size and forecast, by procedure
7.4.4.Asia-Pacific market size and forecast, by service
7.4.5.Asia-Pacific market size and forecast, by end user

7.4.5.1.Japan market size and forecast, by procedure
7.4.5.2.Japan market size and forecast, by service
7.4.5.3.Japan market size and forecast, by end user
7.4.5.4.India market size and forecast, by procedure
7.4.5.5.India Market size and forecast, by service
7.4.5.6.India market size and forecast, by end user
7.4.5.7.China market size and forecast, by procedure
7.4.5.8.China Market size and forecast, by service
7.4.5.9.China Market size and forecast, by end user
7.4.5.10.Australia market size and forecast, by procedure
7.4.5.11.Australia Market size and forecast, by service
7.4.5.12.Australia Market size and forecast, by end user
7.4.5.13.South Korea market size and forecast, by procedure
7.4.5.14.South Korea market size and forecast, by service
7.4.5.15.South Korea market size and forecast, by end user
7.4.5.16.Rest of Asia-Pacific market size and forecast, by procedure
7.4.5.17.Rest of Asia-Pacific Market size and forecast, by service
7.4.5.18.Rest of Asia-Pacific market size and forecast, by end user

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country
7.5.3.LAMEA market size and forecast, by procedure
7.5.4.LAMEA market size and forecast, by service
7.5.5.LAMEA market size and forecast, by end user

7.5.5.1.Latin America market size and forecast, by procedure
7.5.5.2.Latin America market size and forecast, by service
7.5.5.3.Latin America market size and forecast, by end user
7.5.5.4.Middle East market size and forecast
7.5.5.5.Middle East market size and forecast, by service
7.5.5.6.Middle East market size and forecast, by end user
7.5.5.7.Africa market size and forecast
7.5.5.8.Africa market size and forecast, by service
7.5.5.9.Africa market size and forecast, by end user

CHAPTER 8:COMPANY PROFILES

8.1.APOLLO HOSPITALS ENTERPRISE LTD.

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.CARE FERTILITY GROUP LTD.

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Key strategic moves and developments

8.3.CAROLINAS FERTILITY INSTITUTE

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio

8.4.CITY FERTILITY

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Key strategic moves and developments

8.5.FERTILITY ASSOCIATES LIMITED

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio

8.6.GENEA LIMITED

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Key strategic moves and developments

8.7.MEDICOVER GROUP (MEDICOVER FERTILITY and FIRST EGG BANK)

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.roduct portfolio
8.7.5.Business performance

8.8.MONASH IVF GROUP LIMITED

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance
8.8.6.Key strategic moves and developments

8.9.PROGYNY INC.

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance
8.9.6.Key strategic moves and developments

8.10.VIRTUS HEALTH

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments

LIST OF TABLES

TABLE 01.KEY ART AND FERTILITY SERVICES LEGISLATION IN EUROPE: OVERVIEW
TABLE 02.GLOBAL FERTILITY SERVICES MARKET, BY PROCEDURE, 2019–2027 ($MILLION)
TABLE 03.FERTILITY SERVICES MARKET FOR IVF WITH ICSI, BY REGION, 2019–2027 ($MILLION)
TABLE 04.FERTILITY SERVICES MARKET FOR IUI, BY REGION, 2019–2027 ($MILLION)
TABLE 05.FERTILITY SERVICES MARKET FOR IVF WITHOUT ICSI, BY REGION, 2019–2027 ($MILLION)
TABLE 06.FERTILITY SERVICES MARKET FOR SURROGACY, BY REGION, 2019–2027 ($MILLION)
TABLE 07.FERTILITY SERVICES MARKET FOR OTHERS, BY REGION, 2019–2027 ($MILLION)
TABLE 08.GLOBAL FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 09.FERTILITY SERVICES MARKET FOR FRESH NON-DONOR, BY REGION, 2019-2027 ($MILLION)
TABLE 10.FERTILITY SERVICES MARKET FOR FROZEN NON-DONOR, BY REGION, 2019-2027 ($MILLION)
TABLE 11.FERTILITY SERVICES MARKET FOR EGG AND EMBRYO BANKING, BY REGION, 2019-2027 ($MILLION)
TABLE 12.FERTILITY SERVICES MARKET FOR FRESH DONOR, BY REGION, 2019-2027 ($MILLION)
TABLE 13.FERTILITY SERVICES MARKET FOR FROZEN DONOR, BY REGION, 2019-2027 ($MILLION)
TABLE 14.GLOBAL FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 15.FERTILITY SERVICES MARKET FOR IVF FERTILITY CLINICS, BY REGION, 2019-2027 ($MILLION)
TABLE 16.FERTILITY SERVICES MARKET FOR HOSPITALS, BY REGION, 2019-2027 ($MILLION)
TABLE 17.FERTILITY SERVICES MARKET FOR IVF SURGICAL CENTERS, BY REGION, 2019-2027 ($MILLION)
TABLE 18.FERTILITY SERVICES MARKET FOR CLINICAL RESEARCH INSTITUTES, BY REGION, 2019-2027 ($MILLION)
TABLE 19.GLOBAL FERTILITY SERVICES MARKET, BY REGION, 2019-2027 ($MILLION)
TABLE 20.NORTH AMERICA FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 21.NORTH AMERICA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 22.NORTH AMERICA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 23.NORTH AMERICA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 24.U.S. FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 25.U.S. FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 26.U.S. FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 27.CANADA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 28.CANADA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 29.CANADA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 30.MEXICO FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 31.MEXICO FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 32.MEXICO FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 33.EUROPE FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 34.EUROPE FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 35.EUROPE FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 36.EUROPE FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 37.GERMANY FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 38.GERMANY FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 39.GERMANY FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 40.FRANCE FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 41.FRANCE FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 42.FRANCE FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 43.UK FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 44.UK FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 45.UK FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 46.ITALY FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 47.ITALY FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 48.ITALY FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 49.SPAIN FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 50.SPAIN FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 51.SPAIN FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 52.RUSSIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 53.RUSSIA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 54.RUSSIA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 55.REST OF EUROPE FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 56.REST OF EUROPE FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 57.REST OF EUROPE FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 58.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 59.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 60.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 61.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 62.JAPAN FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 63.JAPAN FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 64.JAPAN FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 65.INDIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 66.INDIA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 67.INDIA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 68.CHINA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 69.CHINA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 70.CHINA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 71.AUSTRALIA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 72.AUSTRALIA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 73.AUSTRALIA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 74.SOUTH KOREA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 75.SOUTH KOREA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 76.SOUTH KOREA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 77.ASIA-PACIFIC FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 78.REST OF ASIA-PACIFIC FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 79.REST OF ASIA-PACIFIC FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 80.LAMEA FERTILITY SERVICES MARKET, BY COUNTRY, 2019-2027 ($MILLION)
TABLE 81.LAMEA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 82.LAMEA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 83.LAMEA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 84.LATIN AMERICA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 85.LATIN AMERICA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 86.LATIN AMERICA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 87.MIDDLE EAST FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 88.MIDDLE EAST FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 89.MIDDLE EAST FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 90.AFRICA FERTILITY SERVICES MARKET, BY PROCEDURE, 2019-2027 ($MILLION)
TABLE 91.AFRICA FERTILITY SERVICES MARKET, BY SERVICE, 2019-2027 ($MILLION)
TABLE 92.AFRICA FERTILITY SERVICES MARKET, BY END USER, 2019-2027 ($MILLION)
TABLE 93.APOLLO HOSPITALS: COMPANY SNAPSHOT
TABLE 94.APOLLO HOSPITALS: OPERATING SEGMENTS
TABLE 95.APOLLO HOSPITALS: PRODUCT PORTFOLIO
TABLE 96.CARE FERTILITY: COMPANY SNAPSHOT
TABLE 97.CARE FERTILITY: PRODUCT PORTFOLIO
TABLE 98.CAROLINAS FERTILITY INSTITUTE: COMPANY SNAPSHOT
TABLE 99.CAROLINAS FERTILITY INSTITUTE: PRODUCT PORTFOLIO
TABLE 100.CITY FERTILITY: COMPANY SNAPSHOT
TABLE 101.CITY FERTILITY: PRODUCT PORTFOLIO
TABLE 102.FERTILITY ASSOCIATES: COMPANY SNAPSHOT
TABLE 103.FERTILITY ASSOCIATES: OPERATING SEGMENTS
TABLE 104.FERTILITY ASSOCIATES: PRODUCT PORTFOLIO
TABLE 105.GENEA LIMITED: COMPANY SNAPSHOT
TABLE 106.GENEA LIMITED: OPERATING SEGMENTS
TABLE 107.GENEA LIMITED: PRODUCT PORTFOLIO
TABLE 108.MEDICOVER: COMPANY SNAPSHOT
TABLE 109.MEDICOVER: OPERATING SEGMENTS
TABLE 110.MEDICOVER: PRODUCT PORTFOLIO
TABLE 111.MVF: COMPANY SNAPSHOT
TABLE 112.MVF: PRODUCT PORTFOLIO
TABLE 113.PROGYNY: COMPANY SNAPSHOT
TABLE 114.PROGYNY: PRODUCT PORTFOLIO
TABLE 115.VIRTUS HEALTH: COMPANY SNAPSHOT
TABLE 116.VIRTUS HEALTH: OPERATING SEGMENTS
TABLE 117.VIRTUS HEALTH: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.FERTILITY SERVICES MARKET: MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2017-2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2017-2021 (%)
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2017-2021
FIGURE 06.HIGH BARGAINING POWER OF BUYERS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.HIGH THREAT OF SUBSTITUTION
FIGURE 09.HIGH THREAT OF NEW ENTRANT
FIGURE 10.MODERATE COMPETITIVE RIVALRY
FIGURE 11.MARKET DYNAMICS
FIGURE 12.APOLLO HOSPITALS: NET SALES, 2018–2020 ($MILLION)
FIGURE 13.APOLLO HOSPITALS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 14.MEDICOVER: NET SALES, 2018–2020 ($MILLION)
FIGURE 15.MEDICOVER: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 16.MEDICOVER: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 17.MVF: NET SALES, 2018–2020 ($MILLION)
FIGURE 18.MVF: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 19.PROGYNY: NET SALES, 2018–2020 ($MILLION)
FIGURE 20.PROGYNY: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 21.VIRTUS HEALTH: NET SALES, 2018–2020 ($MILLION)
FIGURE 22.VIRTUS HEALTH: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 23.VIRTUS HEALTH: REVENUE SHARE BY REGION, 2020 (%)

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/

※関連調査資料

不妊治療の世界市場（～2026年）：製品別（機器、培地、付属品）、処置別（ART（IVF、ICSI、代理出産）、授精、腹腔鏡検査、子宮鏡検査）、患者タイプ別（女性、男性）、エンドユーザー別（不妊治療クリニック、病院、研究）
MD3765 / MarketsandMarkets / 2021年10月18日 / マーケッツアンドマーケッツ社は、不妊治療の世界市場規模が2021年15億ドルから2026年22億ドルまで、年平均8.1％成長すると予測しています。本調査レポートは、世界の不妊治療市場について調査し、イントロダクション、調査手法、エグゼクティブサマリー、プレミアムインサイト、市場概要、製品別（機器、培地＆消耗品、付属品）分析、処置別（生殖補助医療（ART）、人工授精、不妊手術、その他）分析、患者タイプ別（女性、男性）分析、エンドユーザー別（不妊治療クリニック、病院＆手術クリニック、精子バンク、研究機関）分析、地域別分析、競争状況、企業情報など、以下の構成でまとめております。・イントロダクション・調査手法...

オンライン音楽ストリーミングの世界市場2021年-2027年：サービス別（オンデマンドストリーミング、ライブストリーミング）、収益モデル別、プラットフォーム別、エンドユーザー別、コンテンツ種類別
AMR21JU008 / Allied Market Research / 2021年5月4日 / 本調査資料では、オンライン音楽ストリーミングの世界市場について調査し、イントロダクション、エグゼクティブサマリー、市場概要、サービス別（オンデマンドストリーミング、ライブストリーミング）分析、収益モデル別（サブスクリプション、非サブスクリプション）分析、プラットフォーム別（アプリ、ブラウザ）分析、エンドユーザー別（個人、商業）分析、地域別分析、競争状況、企業情報などを掲載しています。・イントロダクション・エグゼクティブサマリー...

世界のロボアドバイザリー市場2020年-2027年：ビジネスモデル別（ピュアロボアドバイザー、ハイブリッドロボアドバイザー）、サービスプロバイダー別、サービス別、エンドユーザー別
AMR21MC041 / Allied Market Research / 2021年1月28日 / Allied Market Research社の本調査レポートでは、世界のロボアドバイザリー市場について調査し、イントロダクション、エグゼクティブサマリー、市場概要、ビジネスモデル別（ピュアロボアドバイザー、ハイブリッドロボアドバイザー）分析、プロバイダー別（フィンテックロボアドバイザー、銀行、従来型ウェルスマネージャー、その他）分析、サービス別（直接プランベース・ゴールベース、包括的ウェルスアドバイザリー）分析、エンドユーザー別（個人投資、富裕層）分析、地域別分析、競争状況、企業情報などを掲載しています。...

世界のワークプレイスストレスマネジメント市場2020年-2027年：サービス別（ストレス評価、ヨガ・瞑想、レジリエンストレーニング、進捗追跡指標、その他）、提供方法別、エンドユーザー別
ALD21JU060 / Allied Market Research / 2021年4月 / Allied Market Research社の本調査レポートは、世界のワークプレイスストレスマネジメント市場について調査し、イントロダクション、エグゼクティブサマリー、市場状況、サービス別（ストレス評価、ヨガ・瞑想、レジリエンストレーニング、進捗追跡指標、その他）分析、提供方法別（個別カウンセラー、パーソナルフィットネストレーナー、瞑想専門家、その他）分析、地域別分析、企業情報などを整理しました。...

世界の体外診断市場2020年-2027年：製品＆サービス別（試薬、機器、ソフトウェア＆サービス）、技術別、用途別、エンドユーザー別
AMR21AP017 / Allied Market Research / 2021年2月17日 / Allied Market Research社の本調査レポートでは、世界の体外診断市場について調査し、イントロダクション、エグゼクティブサマリー、市場概要、製品＆サービス別（試薬、機器、ソフトウェア＆サービス）分析、技術別（免疫診断、血液、分子診断、組織診断、臨床化学）分析、用途別（感染症、癌、心臓病、免疫系障害、腎疾患）分析、エンドユーザー別（独立型ラボ、病院、学術＆医学部、ポイントオブケア検査、その他）分析、地域別分析、企業情報などを掲載しています。...

※注目の調査資料

※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(ALD21JU014 )"世界の不妊治療サービス市場2020年-2027年：処置別（ICSI IVF、IUI、非ICSI IVF、代理出産、その他）、サービス別、エンドユーザー別" (英文：Fertility Services Market by Procedure (IVF with ICSI, IUI, IVF without ICSI, Surrogacy, and Others), Service (Fresh Non-donor, Frozen Non-donor, Egg & Embryo Banking, Fresh Donor, and Frozen Donor), and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Global Opportunity Analysis and Industry Forecast, 2020–2027)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

◆H&Iグローバルリサーチのお客様（例）◆